Orion Pharma Limited (DSE:ORIONPHARM)
Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
26.40
+0.20 (0.76%)
At close: Sep 3, 2026

Orion Pharma Cash Flow Statement

Millions BDT. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Net Income
-595.3-415.28318.12640.94846.08939.06
Depreciation & Amortization
576.04634.4588.7601.12498.451,019
Loss (Gain) From Sale of Investments
002.86-0.21-0.085.93
Other Operating Activities
412.3425.53432.84256.66-225.31528.16
Change in Accounts Receivable
-86.15-388.271,3191,004-2,841-1,448
Change in Inventory
561.77192.79-96.0445.45-263.32-133.11
Change in Accounts Payable
66.83667.23-1,134-327.193,2261,603
Change in Other Net Operating Assets
-113.69-12.27155.36272.12-79.377.52
Operating Cash Flow
821.81,1041,5872,4931,1622,592
Operating Cash Flow Growth
-60.79%-30.41%-36.36%114.60%-55.17%37.68%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Capital Expenditures
-421-767.16-1,948-3,859-2,667-4,277
Sale of Property, Plant & Equipment
152.21152.21371.11---
Cash Acquisitions
-61.81-62.94386.09-1,376-379.31-1,633
Investment in Securities
-8.36-8.36-0.220.01-8.60.03
Other Investing Activities
2.8213.4524.0627.2819.6845.44
Investing Cash Flow
-336.14-672.8-1,167-5,208-3,035-5,864

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Short-Term Debt Issued
--16.2111.2387.98392.27
Long-Term Debt Issued
--764.93,3111,7843,131
Total Debt Issued
240.03-781.113,3222,1723,523
Short-Term Debt Repaid
--62.48----
Long-Term Debt Repaid
--281.23-22.33-28.36-33.66-40.63
Total Debt Repaid
-581.03-343.71-22.33-28.36-33.66-40.63
Net Debt Issued (Repaid)
-341-343.71758.783,2932,1383,482
Common Dividends Paid
-0.46-8.21-269.9-152.94-324.54-340.17
Dividends Paid
-0.46-8.21-269.9-152.94-324.54-340.17
Other Financing Activities
-135.89-155.04-890.42-401.76-249.56-488.68
Financing Cash Flow
-477.35-506.96-401.552,7391,5642,654

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Miscellaneous Cash Flow Adjustments
000-00-0
Net Cash Flow
8.31-75.6317.6223.97-308.86-619.18

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Free Cash Flow
400.8336.97-361.87-1,366-1,505-1,685
Free Cash Flow Growth
------
Free Cash Flow Margin
13.31%8.25%-3.41%-9.81%-15.58%-15.56%
Free Cash Flow Per Share
1.711.44-1.55-5.84-6.43-7.20
Levered Free Cash Flow
-545.25269.21-618.16-3,066-1,366-36.58
Unlevered Free Cash Flow
-274.66539.14-372.3-2,974-1,257103.06

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash Interest Paid
371.39155.04890.42401.76249.56488.68
Cash Income Tax Paid
39.5645.65194.54117.0395.7340.91
Change in Working Capital
428.76459.48244.04994.6742.6399.74